JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brauchle, M.
Right arrow Articles by Werner, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brauchle, M.
Right arrow Articles by Werner, S.

Volume 271, Number 36, Issue of September 6, 1996 pp. 21793-21797
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.

Ultraviolet B and H2O2 Are Potent Inducers of Vascular Endothelial Growth Factor Expression in Cultured Keratinocytes*

(Received for publication, April 3, 1996, and in revised form, June 14, 1996)

Maria Brauchle Dagger , Jens Oliver Funk §par , Peter Kind and Sabine Werner Dagger ''

From the Dagger  Max-Planck-Institut für Biochemie, Am Klopferspitz 18a, D-82152 Martinsried, Germany, the § Institut für Klinische Molekularbiologie und Tumorgenetik, GSF-Forschungszentrum für Umwelt und Gesundheit, Marchionistrasse 25, D-81377 München, Germany, and  Abteilung für Molekulare Pathologie, Dermatologische Klinik und Poliklinik der Universität München, Frauenlobstrasse 9-11, D-80337 München, Germany

ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
FOOTNOTES
Acknowledgments
REFERENCES


ABSTRACT

Vascular endothelial growth factor (VEGF), also known as vascular permeability factor, is strongly expressed by epidermal keratinocytes during wound healing, in psoriasis, and in bullous diseases such as erythema multiforme and bullous pemphigoid. All of these disorders are characterized by increased microvascular permeability and angiogenesis. Since the development of erythema as a result of hyperpermeable blood vessels is also a common feature after excess sun exposure, we speculated about an up-regulation of VEGF expression by ultraviolet (UV) light. To test this hypothesis, we analyzed the effect of UVB irradiation on VEGF expression in cultured keratinocytes. Thereby we found a large increase in VEGF mRNA and protein levels upon irradiation of quiescent keratinocytes with sublethal and physiologically relevant doses of UVB. Although H2O2 was also a potent inducer of VEGF expression, the effect of UVB irradiation is unlikely to be mediated by reactive oxygen species as determined by the use of antioxidants. Further experiments revealed that the UVB-induced overexpression of VEGF is dependent on de novo protein synthesis and might occur via release of soluble mediators, which subsequently turn on VEGF expression. In summary, our results suggest a novel role of VEGF in the induction of erythema after excess sun exposure.


INTRODUCTION

Vascular endothelial growth factor (VEGF),1 also known as vascular permeability factor and vasculotropin, is a potent, multifunctional cytokine that exerts several important actions on vascular endothelium (for review, see Ref. 1). VEGF was originally discovered as a tumor-secreted protein that rendered venules and small veins hyperpermeable to circulating macromolecules (2). Subsequent purification and molecular cloning revealed VEGF to be a 34-42-kDa homodimeric, heparin-binding glycoprotein that is secreted by various cell types including keratinocytes (3, 4, 5, 6, 7, 8, 9, 10, 11). Four different VEGF isoforms have been identified which arise from alternative splicing of a single transcript (12, 13). The two larger variants, VEGF189 and VEGF206, remain cell-associated whereas the two smaller forms, VEGF121 and VEGF165, are secreted (13, 14). Two transmembrane type III tyrosine kinases, KDR (15, 16, 17) and flt-1 (18), have been identified as high affinity VEGF receptors. They are expressed predominantly, if not exclusively, by vascular endothelial cells. Overexpression of VEGF and both of its receptors has been documented in a number of animal and human tumors (for review, see Refs. 1 and 19), and VEGF is thought to play an important role in the increased vascular permeability and angiogenesis associated with these malignancies. VEGF is also overexpressed by epidermal keratinocytes in certain non-neoplastic processes of the skin which are characterized by increased microvascular permeability and angiogenesis, e.g. cutaneous wound healing (9) and psoriasis (20). Recently, up-regulation of VEGF was also found in bullous pemphigoid, erythema multiforme, and dermatitis herpetiformis (21), which are all associated with hyperpermeable dermal microvessels.

These findings led us to hypothesize that increased expression of VEGF might also play an important role in the development of sunlight-induced erythema. Exposure to solar ultraviolet B (UVB) radiation is known to induce multiple inflammatory and carcinogenous reactions in the skin (for review, see Ref. 22). Upon UVB irradiation, keratinocytes express several proinflammatory cytokines, including tumor necrosis factor alpha  and interleukin 1alpha and beta  (IL-1alpha and IL-1beta ) (23, 24, 25), which promote reactions of other effector cells in the skin, e.g. leukocytes and endothelial cells. Here we show that low dose UVB irradiation leads to a strong increase in VEGF mRNA and protein levels in human keratinocytes in vitro. Since this increase is not inhibited by antioxidants, reactive oxygen species are unlikely to be involved in the UVB-dependent up-regulation of VEGF. Experiments with cycloheximide and with conditioned medium from UVB-treated cells suggest that the induction of VEGF expression by UVB is indirect and depends on the release of soluble factors that subsequently turn on VEGF expression.


MATERIALS AND METHODS

Cell Culture

The human keratinocyte cell line HaCaT (26) was maintained in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum, penicillin (100 units/ml) and streptomycin (100 µg/ml). For experiments with H2O2, keratinocytes were grown in RPMI 1640 medium supplemented with the same components as above. This medium does not contain iron salts, which are known to promote the decomposition of H2O2. In both cases, cells were grown to confluence without changing the medium and rendered quiescent by a 16-h incubation in serum-free medium. Cells were then incubated for varying periods in serum-free medium containing H2O2, pyrrolidine dithiocarbamate (PDTC), cycloheximide, or conditioned medium from UVB-treated cells. Dulbecco's modified Eagle's medium, RPMI 1640, and fetal bovine serum were purchased from Life Technologies, Inc. PDTC, cycloheximide, and H2O2 were from Sigma.

UVB Irradiation of Cells

For UVB treatment, confluent and quiescent cells were washed twice with phosphate-buffered saline, irradiated while under a thin film of phosphate-buffered saline, and replenished with their own medium thereafter. The UVB source was a parallel bank of three TL20/12 fluorescent tubes (Philips, Hamburg) emitting a continuous spectrum between 280 and 320 nm with a peak emission at 312 nm. Fluence rate at the site of cell irradiation was 0.86 milliwatts/cm2 as measured with a Centra radiometer (Osram, Munich). The UVB doses employed ranged from 5 to 20 mJ/cm2 (exposure time: 7-26 s) and were sublethal for the cells (data not shown). These doses are a realistic representation of the irradiation reaching basal keratinocytes in vivo (27). Aliquots of cells were harvested before and at different time points after UVB irradiation and used for RNA isolation.

RNA Isolation and RNase Protection Assay

RNA isolation was performed as described (28). RNase protection assays were carried out as published recently (29). Briefly, a 159-base pair fragment corresponding to nucleotides 339-498 of the human VEGF121 cDNA (30) was cloned into the transcription vector pBluescript KSII(+) (Stratagene) and linearized at the 5'-end. An antisense transcript was synthesized in vitro using T3 RNA polymerase and [32P]UTP (800 Ci/mmol, Amersham). 20 µg of total cellular RNA was hybridized at 42 °C overnight with 100,000 cpm of the labeled antisense transcript. Hybrids were digested with RNases A and T1 for 1 h at 30 °C. Protected fragments were separated on 5% acrylamide, 8 M urea gels and analyzed by autoradiography. The increase in VEGF mRNA levels was quantitated by PhosphorImager analysis (FUJI BAS 1000, Fuji).

Western Blot Analysis of VEGF Protein

5 ml of serum-free Dulbecco's modified Eagle's medium/10-cm Petri dish was conditioned by UVB-irradiated quiescent HaCaT cells. 8 and 24 h after irradiation the conditioned medium from three Petri dishes was harvested and centrifuged to remove cell debris. Heparin-binding proteins were precipitated from the supernatant with 100 µl of heparin-Sepharose (1:1 slurry; Pharmacia) overnight at 4 °C. Heparin-Sepharose beads were precipitated by centrifugation and washed three times with 20 mM Tris-HCl, pH 7.4, 300 mM NaCl. Heparin-Sepharose-bound proteins were extracted by a 5-min incubation in Laemmli sample buffer at 95 °C and separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. After transfer to nitrocellulose membranes, VEGF proteins were detected using a polyclonal antiserum directed against the amino terminus of VEGF (Santa Cruz Biotechnology) and an alkaline phosphatase detection system (Promega). Conditioned medium from nontreated cells was used as a negative control, whereas a cell lysate from COS cells transiently transfected with a VEGF cDNA was used as a positive control.


RESULTS

Increased VEGF mRNA and Protein Levels after UVB Irradiation in the Human Keratinocyte Cell Line HaCaT

To investigate the role of sunlight on VEGF expression in the skin, we studied the effect of UVB on VEGF expression in the human keratinocyte cell line HaCaT. For this purpose, cells were irradiated with physiologically relevant doses of UVB and harvested at different time points after UVB treatment. As shown in Fig. 1A, low levels of VEGF mRNA were detected in quiescent, nontreated keratinocytes. Within 5 h after UVB irradiation (10 and 20 mJ/cm2), a large induction of VEGF mRNA expression was observed with highest levels 8 h after exposure to 20 mJ of UVB/cm2 (Fig. 1, A and B). At this time point, VEGF mRNA levels were 11-fold higher compared with the basal level. This effect was long lasting, and 24 h after exposure of the cells to UVB, VEGF mRNA levels were still elevated (2-3-fold).


Fig. 1. Induction of VEGF mRNA expression by UVB irradiation occurs in a dose- and time-dependent manner. Panel A, confluent HaCaT cells were rendered quiescent by serum starvation and irradiated with different doses of UVB light as indicated. Total cellular RNA was harvested before and at different time periods after UVB irradiation as indicated. Samples of 20 µg of total cellular RNA from these cells were analyzed for VEGF mRNA expression by RNase protection assay. 1,000 cpm of the hybridization probe was loaded in the lane labeled Probe and used as a size marker. Panel B, the UVB-induced increase in VEGF mRNA as assessed by PhosphorImager analysis is shown. Panel C, three different forms of VEGF mRNA are shown schematically. A 159-nucleotide hybridization probe (indicated with an arrow) which is complementary to the 3'-end of human VEGF121 was used to detect VEGF transcripts. A 159-base pair protected fragment corresponding to the complete hybridization probe is expected for transcripts encoding VEGF121. Two shorter protected fragments of 86 and 73 base pairs are generated by mRNA encoding larger forms of VEGF. The fragments that are protected by the different forms of VEGF are indicated as solid bars below the RNAs.
[View Larger Version of this Image (30K GIF file)]

Four different VEGF proteins have recently been identified in vitro which arise from differential splicing at the 3'-end of VEGF primary transcripts (12, 13). The hybridization probe that we used for RNase protection assays corresponds to the 3'-end of the shortest form of VEGF (VEGF121) and thus enabled us to distinguish among the different isoforms of this growth factor (Fig. 1C). A protected fragment corresponding to the complete coding sequence of the hybridization probe is generated by mRNA encoding VEGF121 (upper band in Fig. 1A), whereas two shorter protected fragments are generated by mRNAs encoding longer variants of VEGF (lower bands in Fig. 1A). mRNAs encoding VEGF121 and other splice variants were induced to a similar extent (Fig. 1A).

To analyze whether the observed increase in VEGF mRNA levels correlates with the production of immunoreactive VEGF protein, conditioned medium from UVB-irradiated and nonirradiated HaCaT cells was analyzed for the presence of VEGF protein. Because of the kinetics of the VEGF induction at the mRNA level, conditioned medium was harvested 8 and 24 h after irradiation, and VEGF protein was enriched by its capacity to bind to heparin-Sepharose. The presence of VEGF protein in the conditioned medium was detected by immunoblotting using a polyclonal antiserum directed against the amino terminus of VEGF, which is identical in all isoforms. As shown in Fig. 2, two VEGF proteins with estimated molecular masses of 17 and 19 kDa were detected in the conditioned medium of UVB-treated cells. The size of these proteins correlates with the expected sizes of the VEGF gene products. A VEGF specific band of about 36 kDa might represent a dimer of VEGF. The highest levels of VEGF protein were found 24 h after irradiation, whereas no VEGF protein was detectable in conditioned medium of nonirradiated cells. As a positive control, we used lysates from COS cells transiently transfected with a VEGF cDNA. As shown in the right lane of Fig. 2, a VEGF specific protein of about 22 kDa was detected in these cells which was not seen in vector-transfected control cells. Taken together these data demonstrate that the increase in VEGF mRNA after UVB irradiation correlates with accumulation of immunoreactive VEGF protein in the medium.


Fig. 2. Induction of VEGF mRNA expression by UVB irradiation correlates with accumulation of VEGF protein in the conditioned medium. Quiescent HaCaT cells were irradiated with 20 mJ of UVB/cm2, and the conditioned medium of three 10-cm Petri dishes was harvested 8 and 24 h after treatment. As a control, conditioned medium from nontreated cells was collected. Heparin-binding proteins were enriched by their capacity to bind to heparin-Sepharose beads and analyzed by immunoblotting for the presence of VEGF protein. Two VEGF proteins of approximately 17 and 19 kDa (indicated with arrows) were detected 8 and 24 h after UVB irradiation. Cell lysate of COS cells transiently transfected with a VEGF cDNA was used as a positive control.
[View Larger Version of this Image (55K GIF file)]

Induction of VEGF Expression by UVB Is Not Mediated by Oxygen Radicals

UV irradiation of cells has been shown to increase the intracellular levels of reactive oxygen species (31). To determine if this effect was responsible for the increase in VEGF expression after UVB exposure, we first analyzed the effect of H2O2 on VEGF mRNA expression in HaCaT cells. As shown in Fig. 3A, treatment of the cells with 1 mM H2O2 caused a strong increase in VEGF mRNA expression. As expected, pretreatment of the cells with the antioxidant PDTC (20 µM) completely abolished the effect of H2O2, whereas PDTC itself did not influence VEGF expression (Fig. 3B). By contrast, no inhibition of the UVB-dependent increase in VEGF mRNA was observed in PDTC-pretreated cells (Fig. 3C). Thus, although H2O2 is a potent inducer of VEGF expression, reactive oxygen species are unlikely to be responsible for VEGF up-regulation by UVB.


Fig. 3. Induction of VEGF mRNA expression by UVB is not mediated by reactive oxygen species. Panel A, keratinocytes were rendered quiescent by serum starvation and treated with 1 mM H2O2 for 5 and 8 h. Samples of 20 µg of total cellular RNA were analyzed for VEGF mRNA expression by RNase protection assay. 50 µg of tRNA was used as a negative control. 1,000 cpm of the hybridization probe was used as a size marker. In the same experiment, the cells were treated for 1 h with PDTC (20 µM) before the addition of H2O2 (1 mM) or treated exclusively with PDTC (panel B). Panel C, quiescent keratinocytes were irradiated with 20 mJ/cm2 UVB with or without pretreatment with PDTC (20 µM). Total cellular RNA was harvested at different time points as indicated, and 20 µg of RNA was analyzed for VEGF expression by RNase protection assay.
[View Larger Version of this Image (37K GIF file)]

Up-regulation of VEGF Expression after UVB Irradiation Is Dependent on de Novo Protein Synthesis

Recent studies from our laboratory have demonstrated the rapid induction of VEGF expression in HaCaT cells by various growth factors within 10-30 min (32). This increase is independent of de novo protein synthesis. By contrast, up-regulation of this gene by UVB occurred only 5-8 h after irradiation, suggesting that de novo protein synthesis might be required for this effect. Therefore, we investigated the effect of the protein synthesis inhibitor cycloheximide on the UVB- and H2O2-induced VEGF expression. As seen with most primary response genes, treatment of quiescent HaCaT cells with this reagent already caused increased VEGF expression (Fig. 4A), and a strong superinduction was seen after addition of both cycloheximide and H2O2 (Fig. 4B). These findings suggest a direct effect of H2O2 on VEGF expression. In contrast, no superinduction was observed after UVB irradiation of cycloheximide-treated cells. Moreover, the cycloheximide-induced VEGF up-regulation was even reduced by UVB (Fig. 4A). Thus, the effect of UVB is most likely to be indirect. To test this hypothesis further, we analyzed the potency of conditioned medium of UVB-treated cells to induce VEGF expression in quiescent HaCaT cells. As shown in Fig. 5A, medium conditioned for 8 or 24 h by UVB-irradiated cells strongly induced VEGF expression. This induction was comparable to the increase seen after the addition of 10% fetal bovine serum. By contrast, conditioned medium from nonirradiated cells had no effect on VEGF expression. This result suggests that UVB irradiation causes release of soluble mediators that subsequently turn on VEGF expression.


Fig. 4. Induction of VEGF mRNA by UVB irradiation is dependent on de novo protein synthesis. Confluent quiescent HaCaT cells were pretreated for 1 h with cycloheximide (10 µg/ml in 0.1% dimethyl sulfoxide (DMSO)) or with the solvent dimethyl sulfoxide (0.1%). Cells were then irradiated with UVB (20 mJ/cm2) (panel A) or incubated in 1 mM H2O2 (panel B). At different time points, total cellular RNA was isolated, and 20 µg was analyzed for expression of VEGF by RNase protection assay.
[View Larger Version of this Image (39K GIF file)]


Fig. 5. Induction of VEGF expression by UVB is mediated by soluble factors. Panel A, conditioned medium (c.m.) from quiescent nontreated (ctr) and from UVB-irradiated keratinocytes (20 mJ/cm2; 8 and 24 h after irradiation) was harvested, and cell debris was removed by centrifugation. Quiescent serum-starved keratinocytes were incubated in the conditioned medium as indicated on the top of the figure. After 4 and 8 h, total cellular RNA was isolated, and 20 µg was analyzed for VEGF mRNA expression by RNase protection assay. 1,000 cpm of the hybridization probe was used as a size marker. An ethidium bromide stain of 1 µg of the same batch of RNA is shown in panel B.
[View Larger Version of this Image (46K GIF file)]


DISCUSSION

Solar radiation causes a variety of biological effects in the skin. Whereas low doses of UV radiation can be useful due to the photosynthesis of vitamin D, larger doses cause sunburn and, when exposure is chronic, can promote tumor formation. Sunburn is characterized by erythema and edema as a result of increased vascular permeability. The mechanisms that underlie these effects have not been elucidated fully. Since erythema is particularly induced by UVB irradiation that only penetrates into the epidermis (33), keratinocyte-derived soluble mediators that diffuse to the dermis are likely to mediate this effect. This diffusion theory is supported by the lag phase between UVB exposure and the appearance of visible erythema and by the increase in the latent period for visible erythema after cooling of the skin (34). The soluble mediators that induce increased vascular permeability have only partially been characterized. Previous studies have suggested an important role of prostaglandins in this process. However, the later stages of erythema cannot be explained fully by the presence of these factors (for review, see Ref. 33). Therefore, additional mediators might contribute to the effect.

One of the most potent vascular permeability factors is VEGF, which is overexpressed in a wide variety of physiological and pathological conditions associated with increased vascular permeability, such as cancer and wound healing and also in erythema seen in several blistering diseases (1, 9, 21). The results described in the present study suggest an additional role of VEGF in UVB-induced erythema. UVB irradiation of cultured keratinocytes resulted in a strong increase in VEGF mRNA and protein levels. These elevated levels might either be due to transcriptional activation of the VEGF gene and/or to increased mRNA stability since both mechanisms have been shown to contribute to the regulation of VEGF mRNA levels (35).

The UVB dose and spectrum used in this study were well comparable to the UVB light reaching the human skin upon sun exposure, suggesting that a similar increase in VEGF expression might occur in vivo. Thus, in addition to prostaglandins, VEGF might contribute further to the induction of erythema by UVB irradiation. This hypothesis is supported by a recent study that demonstrated a synergistic effect of prostaglandin E2 and VEGF in a quantitative model of local plasma leakage in rabbit skin (36), and a similar synergistic effect might occur in human skin after sun exposure.

The effects of UV irradiation are frequently mediated by reactive oxygen species, and increased levels of hydrogen peroxide, hydroxyl radicals, superoxide, and organic hydroperoxides are found in many different cell types following UV exposure (31, 33). These reactive oxygen species are potent modulators of transcription factor activity (37, 38), resulting in significant changes in gene expression. Therefore we speculated about a role of these molecules in the induction of VEGF expression seen after UVB exposure. Indeed, treatment of keratinocytes with H2O2 caused a strong increase in VEGF expression which was blocked by antioxidants. By contrast, antioxidants had no effect on the UVB-induced VEGF expression, suggesting that UVB irradiation and H2O2 induce expression of this gene via different mechanisms. The induction of VEGF expression by UVB in the presence of antioxidants is in agreement with recent results that demonstrated the involvement of reactive oxygen intermediates in the UVA but not in the UVB response (39).

A series of previous studies suggested an important role of tyrosine phosphorylation but not of protein kinase C activation in the induction of gene expression by UVC and UVB (40, 41, 42, 43, 44), and preliminary studies of our laboratory suggest that similar mechanisms might be responsible for the increased expression of VEGF after UVB irradiation. Thus, pretreatment of the cells with protein tyrosine kinase inhibitors blocked the UVB response, whereas protein kinase C inhibitors had no effect.

Interestingly, induction of VEGF expression in keratinocytes by H2O2 and various growth factors and cytokines occurred much more rapidly compared with the induction seen after UVB exposure (32 and data not shown). This finding suggested that indirect mechanisms might be responsible for the UV effect. This hypothesis was supported by the results seen with cycloheximide. Whereas a combination of H2O2 and the protein synthesis inhibitor caused a strong superinduction of VEGF expression, induction of this gene by UVB was reduced slightly in the presence of cycloheximide. The indirect nature of the UVB effect was proven further by the induction of VEGF expression by conditioned medium from UVB-treated keratinocytes. This finding demonstrates that UVB irradiation of these cells causes release of soluble factors that subsequently turn on VEGF expression. Proinflammatory cytokines are the most likely candidates for this effect. Thus, expression of IL-1alpha , IL-1beta , and tumor necrosis factor alpha  have been shown to be induced in keratinocytes by UVB irradiation (23, 24, 25), and expression of these cytokines precedes the increased expression of VEGF in these cells (data not shown). Since IL-1 and tumor necrosis factor alpha  are potent inducers of VEGF expression in HaCaT cells (32), a combined action of these factors might be responsible for induction of VEGF expression by UVB. A similar cytokine-mediated effect has recently been demonstrated for the UVB-induced prostaglandin E2 expression in keratinocytes (45), suggesting that various UV effects could be mediated by these factors.

In summary, our data demonstrate a strong induction of VEGF expression by UVB which is mediated by the release of soluble factors. These findings suggest a novel and important role of VEGF in the induction of erythema after prolonged sun exposure. Future studies using animal models will help to clarify further the role of this multipotent factor in the UVB response in vivo.


FOOTNOTES

*   This work was supported in part by a grant from the Bundesministerium für Bildung und Forschung (to S. W.). The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked ``advertisement'' in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
par    Present address: Fred Hutchinson Cancer Research Center, 1124 Columbia St., Seattle, WA 98104.
''   Supported by a Hermann and Lilly Schilling award for medical research. To whom correspondence should be addressed. Tel.: 49-89-8578-2269; Fax: 49-89-8578-2814.
1   The abbreviations used are: VEGF, vascular endothelial growth factor; UVB, ultraviolet B; UVC, ultraviolet C; IL, interleukin; PDTC, pyrrolidine dithiocarbamate.

Acknowledgments

We thank Dr. Peter Hans Hofschneider for helpful suggestions and support, Frédérique Torterotot for excellent technical assistance, and Dr. H. Weich for the human VEGF cDNA.


REFERENCES

  1. Dvorak, H. F., Brown, L. F., Detmar, M., Dvorak, A. M. (1995) Am. J. Pathol. 146, 1029-1039 [Abstract]
  2. Senger, D. R., Galli, S. J., Dvorak, A. M., Perruzzi, C. A., Harvey, V. S., Dvorak, H. F. (1983) Science 219, 983-985 [Abstract/Free Full Text]
  3. Senger, D. R., Connolly, D., Perruzzi, C. A., Alsup, D., Nelson, R., Leimgruber, R., Feder, J., Dvorak, H. F. (1987) Fed. Proc. 46, 2102
  4. Connolly, D. T., Olander, J. V., Heuvelman, D., Nelson, R., Monsell, R., Siegel, N., Haymore, B. L., Leimgruber, R., Feder, J. (1989) J. Biol. Chem. 264, 20017-20024 [Abstract/Free Full Text]
  5. Senger, D. R., Connolly, D., Van De Water, L., Feder, J., Dvorak, H. F. (1990) Cancer Res. 50, 1774-1778 [Abstract/Free Full Text]
  6. Ferrara, N., Henzel, W. J. (1989) Biochem. Biophys. Res. Commun. 161, 851-858 [CrossRef][Medline] [Order article via Infotrieve]
  7. Gospodarowicz, D., Abraham, J. A., Schilling, J. (1989) Proc. Natl. Acad. Sci. U. S. A. 86, 7311-7315 [Abstract/Free Full Text]
  8. Conn, G., Sodermann, D. D., Schaeffer, M.-T., Wile, M., Hatcher, V. B., Thomas, K. A. (1990) Proc. Natl. Acad. Sci. U. S. A. 87, 1323-1327 [Abstract/Free Full Text]
  9. Brown, L. F., Yeo, K.-T., Berse, B., Yeo, T.-K., Senger, D. R., Dvorak, H. F., Van De Water, L. (1992) J. Exp. Med. 176, 1375-1379 [Abstract/Free Full Text]
  10. Leung, D. W., Cachianes, G., Kuang, W.-J., Goeddel, D. V., Ferrara, N. (1989) Science 246, 1306-1309 [Abstract/Free Full Text]
  11. Keck, P. J., Hauser, S. D., Krivi, G., Sanzo, K., Warren, T., Feder, J., Connolly, D. T. (1989) Science 246, 1309-1312 [Abstract/Free Full Text]
  12. Tischer, E., Mitchell, R., Hartman, T., Silva, M., Gospodarowicz, D., Fiddes, J. C., Abraham, J. A. (1991) J. Biol. Chem. 266, 11947-11954 [Abstract/Free Full Text]
  13. Houck, K. A., Ferrara, N., Winer, J., Cachianes, G., Li, B., Leung, D. W. (1991) Mol. Endocrinol. 5, 1806-1814 [Abstract]
  14. Breier, G., Albrecht, U., Sterrer, S., Risau, W. (1992) Development 114, 521-532 [Abstract]
  15. Terman, B. I., Dougher-Vermazen, M., Carrion, M. E., Dimitrov, D., Armellino, D. C., Gospodarowicz, D., Bohlen, P. (1992) Biochem. Biophys. Res. Commun. 187, 1579-1586 [CrossRef][Medline] [Order article via Infotrieve]
  16. Millauer, B., Wizigmann-Voos, S., Schnuerch, H., Martinez, R., Moller, N. P. H., Risau, W., Ullrich, A. (1993) Cell 72, 835-846 [CrossRef][Medline] [Order article via Infotrieve]
  17. Quinn, T. P., Peters, K. G., De Vries, C., Ferrara, N., Williams, L. T. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 7533-7537 [Abstract/Free Full Text]
  18. de Vries, C., Escobedo, J. A., Ueno, H., Houck, K., Ferrara, N., Williams, L. T. (1992) Science 255, 989-991 [Abstract/Free Full Text]
  19. Folkman, J. (1995) Nat. Med. 1, 27-31 [CrossRef][Medline] [Order article via Infotrieve]
  20. Detmar, M., Brown, L. F., Claffey, K. P., Yeo, K.-T., Kocher, O., Jackman, R. W., Berse, B., Dvorak, H. F. (1994) J. Exp. Med. 180, 1141-1146 [Abstract/Free Full Text]
  21. Brown, L. F., Harrist, T. J., Yeo, K.-T., Stähle-Bäckdahl, M., Jackman, R. W., Berse, B., Tognazzi, K., Dvorak, H. F., Detmar, M. (1995) J. Invest. Dermatol. 104, 744-749 [CrossRef][Medline] [Order article via Infotrieve]
  22. Funk, J. O., Maibach, H. I. (1994) J. Am. Acad. Dermatol. 31, 999-1014 [Medline] [Order article via Infotrieve]
  23. Ansel, J. C., Luger, T. A., Green, I. (1983) J. Invest. Dermatol. 81, 519-523 [CrossRef][Medline] [Order article via Infotrieve]
  24. Kupper, T. S., Chua, A. O., Flood, P., McGuire, H., Gubler, U. (1987) J. Clin. Invest. 80, 430-436
  25. Köck, A., Schwarz, T., Kirnbauer, R., Urbanski, A., Perry, P., Ansel, J. C., Luger, T. A. (1990) J. Exp. Med. 172, 1609-1614 [Abstract/Free Full Text]
  26. Boukamp, P., Petrusevska, R. T., Breitkreutz, D., Hornung, J., Markham, A., Fusenig, N. E. (1988) J. Cell Biol. 106, 761-777 [Abstract/Free Full Text]
  27. Herzinger, T., Funk, J. O., Hillmer, K., Eick, D., Wolf, D. A., Kind, P. (1995) Oncogene 11, 2151-2156 [Medline] [Order article via Infotrieve]
  28. Chomczynski, P., Sacchi, N. (1987) Anal. Biochem. 162, 156-159 [Medline] [Order article via Infotrieve]
  29. Werner, S., Peters, K. G., Longaker, M. T., Fuller-Pace, F., Banda, M. J., Williams, L. T. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 6896-6900 [Abstract/Free Full Text]
  30. Weindel, K., Marmé, D., Weich, H. A. (1992) Biochem. Biophys. Res. Commun. 183, 1167-1174 [CrossRef][Medline] [Order article via Infotrieve]
  31. Pentland, A. P. (1994) Adv. Exp. Med. Biol. 366, 87-97 [Medline] [Order article via Infotrieve]
  32. Frank, S., Hübner, G., Breier, G., Longaker, M. T., Greenhalgh, D. G., Werner, S. (1995) J. Biol. Chem. 270, 12607-12613 [Abstract/Free Full Text]
  33. Shea, C. R., Parrish, J. A. (1991) Physiology, Biochemistry and Molecular Biology of the Skin (Goldsmith, L. A., eds) , 2nd Edition , p. 910, Oxford University Press, Oxford
  34. Shea, C. R., Parrish, J. A. (1982) Arch. Dermatol. Res. 273, 233-239 [CrossRef][Medline] [Order article via Infotrieve]
  35. Shima, D. T., Deutsch, U., D'Amore, P. A. (1995) FEBS Lett. 370, 203-208 [CrossRef][Medline] [Order article via Infotrieve]
  36. Collins, P. D., Connolly, D. T., Williams, T. J. (1993) Br. J. Pharmacol. 109, 195-199 [Medline] [Order article via Infotrieve]
  37. Schreck, R., Rieber, P., Baeuerle, P. A. (1991) EMBO J. 10, 2247-2258 [Medline] [Order article via Infotrieve]
  38. Meyer, M., Schreck, R., Baeuerle, P. A. (1993) EMBO J. 12, 2005-2015 [Medline] [Order article via Infotrieve]
  39. Krutmann, J., Grewe, M. (1995) J. Invest. Dermatol. 105, 67S-70S [CrossRef][Medline] [Order article via Infotrieve]
  40. Büscher, M., Rahmsdorf, H. J., Liftin, M., Karin, M., Herrlich, P. (1988) Oncogene 3, 301-311 [Medline] [Order article via Infotrieve]
  41. Devary, Y., Gottlieb, R. A., Lau, L. F., Karin, M. (1991) Mol. Cell. Biol. 11, 2804-2811 [Abstract/Free Full Text]
  42. Devary, Y., Gottlieb, R. A., Smeal, T., Karin, M. (1992) Cell 71, 1081-1091 [CrossRef][Medline] [Order article via Infotrieve]
  43. Sachsenmaier, C., Radler-Pohl, A., Zinck, R., Nordheim, A., Herrlich, P., Rahmsdorf, H. J. (1994) Cell 78, 963-972 [CrossRef][Medline] [Order article via Infotrieve]
  44. Miller, C. C., Hale, P., Pentland, A. P. (1994) J. Biol. Chem. 269, 3529-3533 [Abstract/Free Full Text]
  45. Grewe, M., Trefzer, U., Ballhorn, A., Gyufko, K., Henninger, H., Krutmann, J. (1993) J. Invest. Dermatol. 101, 528-531 [CrossRef][Medline] [Order article via Infotrieve]

©1996 by The American Society for Biochemistry and Molecular Biology, Inc.



This article has been cited by other articles:


Home page
IOVSHome page
N. Di Girolamo, D. Wakefield, and M. T. Coroneo
UVB-Mediated Induction of Cytokines and Growth Factors in Pterygium Epithelial Cells Involves Cell Surface Receptors and Intracellular Signaling.
Invest. Ophthalmol. Vis. Sci., June 1, 2006; 47(6): 2430 - 2437.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
C. Premanand, M. Rema, M. Z. Sameer, M. Sujatha, and M. Balasubramanyam
Effect of Curcumin on Proliferation of Human Retinal Endothelial Cells under In Vitro Conditions
Invest. Ophthalmol. Vis. Sci., May 1, 2006; 47(5): 2179 - 2184.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. M. Connor, S. Subbaram, K. J. Regan, K. K. Nelson, J. E. Mazurkiewicz, P. J. Bartholomew, A. E. Aplin, Y.-T. Tai, J. Aguirre-Ghiso, S. C. Flores, et al.
Mitochondrial H2O2 Regulates the Angiogenic Phenotype via PTEN Oxidation
J. Biol. Chem., April 29, 2005; 280(17): 16916 - 16924.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Hirakawa, S. Fujii, K. Kajiya, K. Yano, and M. Detmar
Vascular endothelial growth factor promotes sensitivity to ultraviolet B-induced cutaneous photodamage
Blood, March 15, 2005; 105(6): 2392 - 2399.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
K. Podar and K. C. Anderson
The pathophysiologic role of VEGF in hematologic malignancies: therapeutic implications
Blood, February 15, 2005; 105(4): 1383 - 1395.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
M. D. Wheeler, O. M. Smutney, and R. J. Samulski
Secretion of Extracellular Superoxide Dismutase From Muscle Transduced With Recombinant Adenovirus Inhibits the Growth of B16 Melanomas in Mice
Mol. Cancer Res., October 1, 2003; 1(12): 871 - 881.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
V. A. Shatrov, V. V. Sumbayev, J. Zhou, and B. Brune
Oxidized low-density lipoprotein (oxLDL) triggers hypoxia-inducible factor-1{alpha} (HIF-1{alpha}) accumulation via redox-dependent mechanisms
Blood, June 15, 2003; 101(12): 4847 - 4849.
[Abstract] [Full Text] [PDF]


Home page
Arch DermatolHome page
J. H. Chung, K. Yano, M. K. Lee, C. S. Youn, J. Y. Seo, K. H. Kim, K. H. Cho, H. C. Eun, and M. Detmar
Differential Effects of Photoaging vs Intrinsic Aging on the Vascularization of Human Skin
Arch Dermatol, November 1, 2002; 138(11): 1437 - 1442.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. C. A. Duyndam, T. M. Hulscher, D. Fontijn, H. M. Pinedo, and E. Boven
Induction of Vascular Endothelial Growth Factor Expression and Hypoxia-inducible Factor 1alpha Protein by the Oxidative Stressor Arsenite
J. Biol. Chem., December 14, 2001; 276(51): 48066 - 48076.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. Cho, T. K. Hunt, and M. Z. Hussain
Hydrogen peroxide stimulates macrophage vascular endothelial growth factor release
Am J Physiol Heart Circ Physiol, May 1, 2001; 280(5): H2357 - H2363.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
I. Kosmidou, A. Xagorari, C. Roussos, and A. Papapetropoulos
Reactive oxygen species stimulate VEGF production from C2C12 skeletal myotubes through a PI3K/Akt pathway
Am J Physiol Lung Cell Mol Physiol, April 1, 2001; 280(4): L585 - L592.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
C. Berking, R. Takemoto, K. Satyamoorthy, R. Elenitsas, and M. Herlyn
Basic Fibroblast Growth Factor and Ultraviolet B Transform Melanocytes in Human Skin
Am. J. Pathol., March 1, 2001; 158(3): 943 - 953.
[Abstract] [Full Text] [PDF]


Home page
Arch SurgHome page
A. Y. Sheikh, J. J. Gibson, M. D. Rollins, H. W. Hopf, Z. Hussain, and T. K. Hunt
Effect of Hyperoxia on Vascular Endothelial Growth Factor Levels in a Wound Model
Arch Surg, November 1, 2000; 135(11): 1293 - 1297.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Lu, T. Kasama, K. Kobayashi, Y. Yoda, F. Shiozawa, M. Hanyuda, M. Negishi, H. Ide, and M. Adachi
Vascular Endothelial Growth Factor Expression and Regulation of Murine Collagen-Induced Arthritis
J. Immunol., June 1, 2000; 164(11): 5922 - 5927.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. V. Diaz, M.-C. Lenoir, A. Ladoux, C. Frelin, M. Demarchez, and S. Michel
Regulation of Vascular Endothelial Growth Factor Expression in Human Keratinocytes by Retinoids
J. Biol. Chem., January 7, 2000; 275(1): 642 - 650.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
G. Neufeld, T. Cohen, S. Gengrinovitch, and Z. Poltorak
Vascular endothelial growth factor (VEGF) and its receptors
FASEB J, January 1, 1999; 13(1): 9 - 22.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
T. Suhara, K. Fukuo, T. Sugimoto, S. Morimoto, T. Nakahashi, S. Hata, M. Shimizu, and T. Ogihara
Hydrogen Peroxide Induces Up-Regulation of Fas in Human Endothelial Cells
J. Immunol., April 15, 1998; 160(8): 4042 - 4047.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brauchle, M.
Right arrow Articles by Werner, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brauchle, M.
Right arrow Articles by Werner, S.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1996 by the American Society for Biochemistry and Molecular Biology.